Clinical Trial Update: Patient Registry of Intrathecal Ziconotide Management(PRIZM)

View source ↗

Summary

Jazz Pharmaceuticals reports the PRIZM patient registry for intrathecal ziconotide management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Prialt (ziconotide)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Patients With Severe Chronic Pain | Status: COMPLETED